(MENAFN- The Peninsula) The Peninsula
Doha: Weill Cornell Medicine-Qatar (WCM-Q) clinician and researcher Dr. Rayaz Malik (pictured) has been ranked among the world's leading experts in the fields of diabetic neuropathy and diabetes complications.
Dr. Malik, professor of medicine and assistant dean for clinical investigations at WCM-Q, was ranked 7th for diabetic neuropathies (nerve damage) and 13th for diabetes complications, in a ranking of the most influential clinical researchers across the world.
This list was independently compiled by Expertscape, the world's leading index of academic achievement and expertise in healthcare. It ranks the performance of researchers impartially, using a series of objective metrics to judge the number and quality of research papers and the impact factor of the journals in which they have been published over the last ten years.
Expertscape's analysis determined that Dr. Malik's record of publication over the past ten years puts him in the top 0.0076 percent of 170,863 published authors for diabetes complications worldwide. Diabetes complications include heart disease, stroke, damage to the eye (retinopathy), kidneys (nephropathy) and nerves (neuropathy).
Dr. Malik said:“It is very gratifying to achieve such recognition based on approximately 280 publications since my arrival in Qatar, arising from excellent collaborations between Weill Cornell Medicine-Qatar, Hamad Medical Corporation, Sidra Medicine, and Qatar University. We believe our innovative approach to identify nerve damage is and will have a major impact on the health of people with diabetes and other neurodegenerative diseases.”
Dr. Malik is also a practicing physician, treating patients with diabetes and endocrine diseases at Hamad Medical Corporation.
MENAFN04022023000063011010ID1105523542
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.